Loading [Contrib]/a11y/accessibility-menu.js

Metrics
Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain

Carlos Rubio-Terrés, Ruth Graefenhain de Codes, Darío Rubio-Rodríguez, Thomas Evers, Santiago Grau Cerrato,
• https://doi.org/10.36469/9823

Pageviews and PDF downloads

185 all time Last 7 daysLast 30 daysLast 90 daysAll time
Top Countries
AT34
ES32
US27
GB25
DE13
IN7
DZ5
PL4
CL3
IQ3